L
LifeBond
Manufactures medical devices for biosurgery and tissue repair in an effort to save lives and reduce postoperative complications
About LifeBond
LifeBond is a medical technology company specializing in advanced hemostatic solutions designed to control surgical bleeding and improve patient outcomes. Operating in the healthcare and medical devices market, LifeBond serves hospitals, surgical centers, and healthcare professionals who require reliable and effective bleeding control products. The company's business model revolves around the development, manufacturing, and distribution of its proprietary hemostatic products, which generate revenue through direct sales and partnerships with medical distributors. LifeBond's innovative products are designed to enhance surgical safety, reduce complications, and improve overall patient care, making it a valuable player in the medical technology industry.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2007
- Headquarters
- Keisarya, Israel
- Open positions
- None listed
- Dealroom signal
- 58.8/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Surgery, Biomaterials, Tissue Engineering, Soft Tissues, Chemical, Hospital, Tech for Hospitals and Clinics, Biotech and Pharma, Hard Tech
- Business model
- Manufacturing
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jan 2020 | $60M | $60M | C. R. Bard | ↗ |
| SERIES DOther financing | Aug 2015 | $27M | $108M | Pitango Venture Capital · Giza Venture Capital · GlenRock Israel · BizTEC | — |
Growth signals
Latest recorded traffic for LifeBond is 170 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Trendlines Group
Series A4 investors entered at this stage
The Zitelman Group
GlenRock Israel
Pitango Venture Capital
Robert Taub
Series B and later3 investors entered at this stage
Giza Venture Capital
Aurum Ventures
BizTEC
Other known investors1 additional known investor
- CBC. R. Bard
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about LifeBond on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LifeBond’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





